1. Home
  2. BNOX vs BMRA Comparison

BNOX vs BMRA Comparison

Compare BNOX & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNOX
  • BMRA
  • Stock Information
  • Founded
  • BNOX 1996
  • BMRA 1971
  • Country
  • BNOX Australia
  • BMRA United States
  • Employees
  • BNOX N/A
  • BMRA N/A
  • Industry
  • BNOX Biotechnology: Biological Products (No Diagnostic Substances)
  • BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • BNOX Health Care
  • BMRA Health Care
  • Exchange
  • BNOX Nasdaq
  • BMRA Nasdaq
  • Market Cap
  • BNOX 6.3M
  • BMRA 7.4M
  • IPO Year
  • BNOX 2021
  • BMRA N/A
  • Fundamental
  • Price
  • BNOX $0.27
  • BMRA $0.31
  • Analyst Decision
  • BNOX Strong Buy
  • BMRA
  • Analyst Count
  • BNOX 1
  • BMRA 0
  • Target Price
  • BNOX $8.00
  • BMRA N/A
  • AVG Volume (30 Days)
  • BNOX 691.4K
  • BMRA 2.3M
  • Earning Date
  • BNOX 01-01-0001
  • BMRA 01-14-2025
  • Dividend Yield
  • BNOX N/A
  • BMRA N/A
  • EPS Growth
  • BNOX N/A
  • BMRA N/A
  • EPS
  • BNOX N/A
  • BMRA N/A
  • Revenue
  • BNOX N/A
  • BMRA $5,509,000.00
  • Revenue This Year
  • BNOX N/A
  • BMRA N/A
  • Revenue Next Year
  • BNOX N/A
  • BMRA N/A
  • P/E Ratio
  • BNOX N/A
  • BMRA N/A
  • Revenue Growth
  • BNOX N/A
  • BMRA 1.74
  • 52 Week Low
  • BNOX $0.18
  • BMRA $0.24
  • 52 Week High
  • BNOX $1.60
  • BMRA $1.51
  • Technical
  • Relative Strength Index (RSI)
  • BNOX 47.76
  • BMRA 47.80
  • Support Level
  • BNOX $0.27
  • BMRA $0.27
  • Resistance Level
  • BNOX $0.35
  • BMRA $0.48
  • Average True Range (ATR)
  • BNOX 0.03
  • BMRA 0.04
  • MACD
  • BNOX 0.00
  • BMRA -0.00
  • Stochastic Oscillator
  • BNOX 18.78
  • BMRA 23.86

About BNOX Bionomics Limited American Depository Shares

Bionomics Ltd is a clinical-stage biopharmaceutical company. It is primarily engaged in the development of therapeutics for diseases of the central nervous system and cancer. The company's reportable segment is the Drug Discovery and Development segment which is engaged in the discovery, development, and commercialization of compounds to match a target product profile. The company generates all of its revenues from Australia.

About BMRA Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.

Share on Social Networks: